Free Trial

Aurora Cannabis (ACB) Stock Price, News & Analysis

-0.16 (-2.71%)
(As of 06/14/2024 ET)
Today's Range
50-Day Range
52-Week Range
794,539 shs
Average Volume
1.60 million shs
Market Capitalization
$313.12 million
P/E Ratio
Dividend Yield
Price Target

Aurora Cannabis MarketRank™ Stock Analysis

Analyst Rating
Short Interest
28.21% of Float Sold Short
Dividend Strength
News Sentiment
0.96mentions of Aurora Cannabis in the last 14 days
Based on 3 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($0.65) to ($0.32) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.36 out of 5 stars

Medical Sector

892nd out of 915 stocks

Medicinals & Botanicals Industry

13th out of 13 stocks

ACB stock logo

About Aurora Cannabis Stock (NASDAQ:ACB)

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

ACB Stock Price History

ACB Stock News Headlines

Short Interest in Aurora Cannabis Inc. (NASDAQ:ACB) Declines By 17.2%
Is Aurora Cannabis Stock a Buy?
The 3 Best Cannabis Stocks to Buy in May 2024
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
Wall Street Lunch: Reefer Gladness
See More Headlines
Receive ACB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Confirmed)
Fiscal Year End

Industry, Sector and Symbol

Medicinals & botanicals
Current Symbol
Year Founded


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$174.88 million


Free Float
Market Cap
$313.12 million

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Miguel Martin (Age 51)
    CEO & Director
    Comp: $1.48M
  • Mr. Alex Miller
    Executive Vice President of Operations & Supply Chain
  • Ms. Lori Schick
    Executive Vice President of Human Resources
  • Mr. Andre Jerome
    Executive Vice President of Global Business Development
  • Ms. Simona King (Age 51)
    Chief Financial Officer
  • Ananth Krishnan
    Vice President of Capital Markets & Investor Relations
  • Ms. Nathalie Clark
    Executive VP, General Counsel & Corporate Secretary
  • Michelle Lefler
    Vice President of Communications & Public Relations
  • Dr. Jonathan Page Ph.D. (Age 55)
    Senior Science Advisor
  • Mr. Rick Savone
    Senior Vice President of Global Government Relations

ACB Stock Analysis - Frequently Asked Questions

Should I buy or sell Aurora Cannabis stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ACB shares.
View ACB analyst ratings
or view top-rated stocks.

How have ACB shares performed in 2024?

Aurora Cannabis' stock was trading at $4.7620 on January 1st, 2024. Since then, ACB stock has increased by 20.5% and is now trading at $5.74.
View the best growth stocks for 2024 here

Are investors shorting Aurora Cannabis?

Aurora Cannabis saw a drop in short interest in May. As of May 31st, there was short interest totaling 4,370,000 shares, a drop of 17.2% from the May 15th total of 5,280,000 shares. Based on an average daily volume of 7,720,000 shares, the days-to-cover ratio is currently 0.6 days. Currently, 28.2% of the shares of the stock are short sold.
View Aurora Cannabis' Short Interest

When is Aurora Cannabis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 20th 2024.
View our ACB earnings forecast

How can I listen to Aurora Cannabis' earnings call?

Aurora Cannabis will be holding an earnings conference call on Thursday, June 20th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (NASDAQ:ACB) issued its quarterly earnings results on Wednesday, May, 12th. The company reported ($8.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.70) by $6.50. The firm had revenue of $43.56 million for the quarter, compared to analysts' expectations of $55.17 million. Aurora Cannabis had a negative trailing twelve-month return on equity of 23.27% and a negative net margin of 48.82%.

When did Aurora Cannabis' stock split?

Aurora Cannabis's stock reverse split on the morning of Tuesday, February 20th 2024. The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are Aurora Cannabis' major shareholders?

Aurora Cannabis' stock is owned by a variety of institutional and retail investors. Top institutional investors include Mirae Asset Global Investments Co. Ltd. (4.21%), Simplex Trading LLC (0.00%), Virtu Financial LLC (0.30%), Walleye Trading LLC (0.00%), Headlands Technologies LLC (0.07%) and Concurrent Investment Advisors LLC (0.04%).

How do I buy shares of Aurora Cannabis?

Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Aurora Cannabis have any subsidiaries?
The following companies are subsidiares of Aurora Cannabis: 1769474 Alberta Ltd., 2105657 Alberta Inc., ACB Captive Insurance Company Inc., Anandia Labs Inc, Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Aurora Nordic Cannabis A/S, CanniMed Therapeutics Inc., CanvasRx Holdings, ICC Labs Inc., Larssen Ltd, MedReleaf Corp., Pedanios, Peloton Pharmaceuticals Inc., Reliva LLC, Reliva LLC, Whistler Medical Marijuana Corporation, and Whistler Medical Marijuana Corporation.
Read More
This page (NASDAQ:ACB) was last updated on 6/15/2024 by Staff

From Our Partners